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Cellular senescence acts as a physiological barrier 
against uncontrolled proliferation of cells with 
potentially harmful alterations, contributing to tumor 
suppression and tissue homeostasis in live organisms 
[1]. Senescence is a complex phenotype that involves 
major changes in cellular function and structure. This 
phenotype is characterized by a specific gene 
expression program, which is controlled by key 
transcriptional regulators as well as by global and gene-
specific epigenetic changes. In addition, the post-
transcriptional control of senescence mediated by non-
coding RNAs has recently attracted much interest [1]. 
In this context, our recent results [2] provide new 
evidence that supports the notion that microRNA-
mediated control of gene expression plays a critical 
regulatory role in cellular senescence. 
MicroRNAs are small noncoding RNAs that negatively 
regulate gene expression primarily through the 
degradation or translation inhibition of mRNAs with 
complementary sequences. To examine the impact of 
global disruption of miRNA activity in primary cells we 
focused on DGCR8 (also known as Pasha), an essential 
factor required for early steps of miRNA synthesis. 
Together with the ribonuclease DROSHA, DGCR8 
forms the so-called Microprocessor nuclear complex, 
which is responsible of the processing of primary 
miRNA transcripts to generate the pre-miRNA 
intermediates that are further processed by Dicer to 
yield mature miRNAs [3]. We found that the disruption 
of miRNA biogenesis by silencing of DGCR8 behaved 
as a potent pro-senescence stimulus in human and 
mouse primary fibroblasts, leading to a clear reduction 
in proliferation, and the acquisition of classical 
senescence markers including flattened morphology, 
SA-BetaGal activity or formation of SAHF.  Silencing 
of other key miRNA regulators, such as DROSHA or 
DICER had similar effects, supporting the notion that 
this phenotype was associated to global disruption of 
miRNA activity. 
Our data ruled out that the induction of senescence 
observed could be due to indirect activation of 
oncogenes, DNA damage, or global changes in 
chromatin.  Instead, we hypothesized that the silencing 
of the miRNA regulator DGCR8  could  have  subverted  
 
 
 
                                                                     Editorial 
 
 
 
 
 
 
 
the physiological regulation of senescence by miRNAs.  
In our search for specific candidate miRNAs, we noted  
a significant overlap between miRNAs down-regulated 
during MEK-induced senescence and a set of miRNAs 
previously associated with cell-cycle defects in Dgcr8-
defective ES cells [4]. This group of miRNAs included 
miR-20a, miR-106a and miR-93, a subset of miRNAs 
from the miR-17-92 family with identical seed 
sequences, and potentially common downstream targets. 
Interestingly, the miR-17-92 cluster and its paralogs 
have oncogenic features, since they are frequently 
overexpressed in tumors, and promote oncogenic 
transformation [5]. We found that this specific subset of 
miRNAs was down-regulated during senescence due to 
miRNA disruption, and the forced expression of miR-93 
could overcome DGCR8-mediated senescence. Notably, 
it has been reported that several miRNAs of this group 
can also bypass senescence induced by the Ras 
oncogene in fibroblasts or epithelial cells [6, 7], 
highlighting the importance of these miRNAs as critical 
negative regulators of senescence. 
Searching for downstream effectors of this response, we 
observed that the cdk inhibitor p21CIP1 was 
consistently increased during senescence due to DGCR8 
knockdown. p21 is a direct transcriptional target of p53 
and the role of the p53/p21 pathway in senescence is 
well known. In addition, p21CIP1 expression is also 
repressed by binding of specific miRNAs to its 3’UTR 
region. Of note, our subset of senescence-suppressive 
miRNAs were able to target the p21CIP1 mRNA for 
degradation, and the over-expression of miR-93 was 
capable of reverting, at least in part, the induction of 
p21 seen in DGCR8-deficient senescent cells. However, 
additional effectors must cooperate in the DGCR8-
mediated response, since p21 was found to be 
dispensable, at least in murine fibroblasts. Indeed, we 
identified a number of additional cell-cycle genes 
differentially regulated during DGCR8-dependent 
senescence, which might play a role in the arrest. 
Interestingly, we also found that the anti-proliferative 
response to disrupted miRNA biogenesis is essentially 
retained in non-primary cells.  In a limited survey of 
immortalized and tumor cell lines, we observed similar 
regulation of miRNAs, as well as p21CIP1, but 
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intriguingly, a clear senescent phenotype was not 
induced in this case. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Our results are consistent with the notion that global 
impairment of miRNA function is associated with 
reduced proliferation, in line with evidence from mouse 
models of defective miRNA regulators [4]. Although 
alternative pathways remain possible, our data suggest 
that senescence triggered by impaired miRNA 
biogenesis is primarily due to the reduction below a 
critical threshold of key senescence-suppressive 
miRNAs, which in turn trigger a downstream pro-
senescent cascade. Our findings thus provide new 
evidence in support of the role of specific miRNAs as 
critical negative regulators of senescence. Several 
interesting questions remain open, including the 
involvement of additional downstream effectors, the 
crosstalk between pro and anti-senescence miRNAs, the 
differences between primary and tumor cell lines, or the 
potential role in this context of newly identified 
functions of DGCR8 beyond miRNA processing (see 
[8]). Given the emerging relevance of senescence in 
various physiological processes, it is increasingly 
important to understand the regulatory circuits that 
govern this response. miRNAs are clearly emerging as 
critical regulators of senescence, and further work lies 
ahead to fully unravel the complexity of miRNA-
mediated regulation of cellular senescence. 
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Figure  1.  In  proliferating  primary  cells,  a  proficient  miRNA
biogenesis machinery maintains the correct balance of miRNA
expression,  including  high  levels  of  senescence‐suppressive
miRNAs.  Upon  DGCR8‐mediated  disruption  of  miRNA
biogenesis,  senescence‐suppresive  miRNAs  are  down‐
regulated,  leading  to  activation  of  a  pro‐senescent  cascade.
See text for details and discussion of alternative pathways. 
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